AK
Ankur Kirtikumar Mehta
About Ankur Kirtikumar Mehta
Data last updated:
Ankur Kirtikumar Mehta is a Managing Director at Corona Remedies Limited (since 2004) and Designated Partner at Klnext Enterprise Llp (since 2024). The companies operate in Pharma and BFSI. The largest current company by reported revenue is Corona Remedies Limited at ₹1,202 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 27 Aug 2004 | 2004 | ₹1,202 Cr (FY 2025) | Active | |
| Designated Partner | 10 Oct 2024 | 2024 | Active |
Board colleagues of Ankur Kirtikumar Mehta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ameetkumar Hiranyakumar Desai | 00007116 | Corona Remedies Limited | Director |
| Bhaskar Vemban Iyer | 00480341 | Corona Remedies Limited | Director |
| Bhavin Nareshbhai Bhagat | Corona Remedies Limited | Cfo | |
| Chetna Prabhatkumar Dharajiya | Corona Remedies Limited | Company Secretary | |
| Kirtikumar Laxmidas Mehta | 00385658 | Corona Remedies Limited | Director |
| Monica Hemal Kanuga | 06919996 | Corona Remedies Limited | Director |
| Niravkumar Kirtikumar Mehta | Corona Remedies Limited | Ceo | |
| Niravkumar Kirtikumar Mehta | 01644041 | Corona Remedies Limited | Managing Director |
| Shirish Gundopant Belapure | 02219458 | Corona Remedies Limited | Director |
| Viral Sitwala | 02907957 | Corona Remedies Limited | Whole-Time Director |
| Brinda Mehta | 00386499 | Klnext Enterprise Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ankur Kirtikumar Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankur Kirtikumar Mehta
Ankur Kirtikumar Mehta currently holds 2 directorships: Corona Remedies Limited (Managing Director, since 27 Aug 2004, revenue ₹1,202 Cr (FY 2025)); Klnext Enterprise Llp (Designated Partner, since 10 Oct 2024).
Ankur Kirtikumar Mehta was first appointed on 27 Aug 2004 as Managing Director at Corona Remedies Limited. The most recent appointment on record is 10 Oct 2024 at Klnext Enterprise Llp.
The current boards of Ankur Kirtikumar Mehta's companies include Ameetkumar Hiranyakumar Desai (Corona Remedies Limited), Bhaskar Vemban Iyer (Corona Remedies Limited), Bhavin Nareshbhai Bhagat (Corona Remedies Limited), Chetna Prabhatkumar Dharajiya (Corona Remedies Limited), Kirtikumar Laxmidas Mehta (Corona Remedies Limited), Monica Hemal Kanuga (Corona Remedies Limited), among others.